Skip to main content

Many U.S. Seniors Do Not Intend to Vaccinate Against RSV

Medically reviewed by Carmen Pope, BPharm. Last updated on March 14, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, March 13, 2024 -- Many U.S. seniors do not intend to vaccinate against respiratory syncytial virus (RSV) in the 2023 to 2024 season, according to a study published online Jan. 19 in Health Affairs Scholar.

Simon F. Haeder, Ph.D., from Texas A&M University in College Station, queried Americans older than age 60 years about their RSV vaccination status and their intention to vaccinate this fall and winter in a large national survey.

Haeder found that 9 percent of those surveyed had already been vaccinated; 42 percent of those who were unvaccinated indicated their intent to vaccinate. The likelihood of seeking out vaccinations was increased for those with higher levels of concern for the disease, higher levels of self-assessed risk, and higher levels of trust in health institutions; those believing the vaccines were safe and important; and men. Lack of necessity, concerns about side effects and safety, and a lack of information were primary reasons for vaccine-hesitant respondents.

"Policymakers ought to respond to these findings by implementing evidence-based policies that increase vaccination rates in the immediate as well as long-term future," Haeder writes. "These efforts should focus on highlighting the safety and importance of vaccines as well as the potential risks to individuals who fail to vaccinate."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.